NasdaqGM - Delayed Quote USD

ProShares Ultra Nasdaq Biotechnology (BIB)

49.66 +0.72 (+1.47%)
At close: April 26 at 4:00 PM EDT

Performance Overview: BIB

Trailing returns as of 4/26/2024. Category is Trading--Leveraged Equity.

YTD Return

BIB
12.89%
Category
--

1-Year Return

BIB
8.46%
Category
--

3-Year Return

BIB
18.65%
Category
--

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
BIB
Category
YTD
0.82%
0.00%
1-Month
-0.40%
0.00%
3-Month
0.82%
0.00%
1-Year
6.23%
0.00%
3-Year
-11.64%
0.00%
5-Year
0.79%
0.00%
10-Year
3.73%
0.00%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
BIB
Category
2023
-1.05%
--
2022
-28.85%
--
2021
-6.02%
--
2020
39.79%
--
2019
46.71%
--
2018
-24.93%
--
2017
40.49%
--
2016
-44.17%
--

2015
13.93%
--
2014
66.79%
--
2013
159.60%
--
2012
66.77%
--
2011
15.56%
--

ETF Summary

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

ETF Overview

Category Trading--Leveraged Equity
Fund Family ProShares
Net Assets 96.36M
YTD Daily Total Return -12.89%
Yield 0.14%
Legal Type Exchange Traded Fund

Related Tickers